First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India

Tenzin Tsundue,Tenzin Tsewang,Richard E Chaisson,Tenzin Namdon,Tsering Choetso,Amita Gupta,Zorba Paster,Dawa Phunkyi,Kunchok Dorjee,Tenzin Woesal,David Peters,Tashi Dolma,Tsetan Dorji Sadutshang,Sonam Topgyal,Dekyi Lhadon,Tenzin Yangkyi

doi:10.1136/bmjgh-2021-008271

First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India

Tenzin Tsundue, Tenzin Tsewang + Show 14 more

Open Access

https://doi.org/10.1136/bmjgh-2021-008271

Copy DOI

Journal: BMJ Global Health	Publication Date: May 1, 2022
Citations: 9	License type: open-access

Affiliation: Tibetan Delek Hospital, Johns Hopkins University, Dr. Rajendra Prasad Government Medical College

#Previous History Of Tuberculosis #Facilities In India + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

ObjectivesThis study aimed to determine the effectiveness of Covishield vaccine among residents of congregate residential facilities.DesignA prospective cohort study in congregate residential facilities.SettingDharamshala, Himachal Pradesh, India, from December 2020 to...

Full Text